Molina Healthcare (MOH) Stock Forecast & Price Target

Compare

861 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MOH Analyst Ratings

Moderate Buy

7 Buy

3 Hold

1 Sell

Based on 11 analysts giving stock ratings to

Molina

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MOH Stock 12 Month Forecast

Average Price Target

$370.60

▲(27.68%Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Molina Healthcare in the last 3 months. The average price target is $370.60 with a high forecast of $414.00 and a low forecast of $309.00. The average price target represents a 27.68% change from the last price of $290.25.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"290":"$290","415":"$415","321.25":"$321.3","352.5":"$352.5","383.75":"$383.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":414,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$414.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":370.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$370.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":309,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$309.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[290,321.25,352.5,383.75,415],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,297.35,306.32307692307694,315.29615384615386,324.2692307692308,333.2423076923077,342.2153846153846,351.1884615384615,360.1615384615385,369.13461538461536,378.10769230769233,387.0807692307692,396.05384615384617,405.0269230769231,{"y":414,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,297.35,302.9846153846154,308.6192307692308,314.25384615384615,319.88846153846157,325.5230769230769,331.15769230769234,336.7923076923077,342.4269230769231,348.0615384615385,353.6961538461539,359.33076923076925,364.96538461538466,{"y":370.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,297.35,298.24615384615385,299.1423076923077,300.03846153846155,300.9346153846154,301.83076923076925,302.7269230769231,303.62307692307695,304.5192307692308,305.4153846153846,306.3115384615385,307.2076923076923,308.1038461538462,{"y":309,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":314.58,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":292.16,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":346.19,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":349.79,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":341.91,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":326.75,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":301.87,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.05,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":310.41,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":301.12,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.71,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":313.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.35,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$414.00

Average Price Target$370.60

Lowest Price Target$309.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$350

Buy

20.59%

Upside

Reiterated

05/23/25

Molina Healthcare's strong financial performance and strategic growth initiatives are the most significant factors driving the score. Technical analysis indicates mixed signals, while valuation suggests the stock is fairly valued. Despite challenges in certain segments, the company's strategic planning supports a positive outlook.

Erin WrightMorgan Stanley

Morgan Stanley

$364

Buy

25.41%

Upside

Initiated

06/09/25

Molina Healthcare initiated with an Overweight at Morgan StanleyMolina Healthcare initiated with an Overweight at Morgan Stanley

Andrew Mok CFABarclays

Barclays

$351→$347

Hold

19.55%

Upside

Reiterated

06/09/25

Barclays Remains a Hold on Molina Healthcare (MOH)

Lance WilkesBernstein

Bernstein

$414

Buy

42.64%

Upside

Reiterated

06/06/25

Molina Healthcare (MOH) Receives a Buy from Bernstein

Stephen BaxterWells Fargo

Wells Fargo

$403→$372

Buy

28.17%

Upside

Reiterated

06/05/25

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (NYSE: MOH), Zai Lab (NASDAQ: ZLAB) and Guardant Health (NASDAQ: GH)

David S MacdonaldTruist Financial

Truist Financial

$400

Buy

37.81%

Upside

Reiterated

04/28/25

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (NYSE: MOH), Neurocrine (NASDAQ: NBIX) and Viking Therapeutics (NASDAQ: VKTX)

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$356

Buy

22.65%

Upside

Reiterated

04/24/25

Cantor Fitzgerald reiterates Overweight Rating on Molina Healthcare (MOH)Cantor Fitzgerald analyst Sarah Jameas reiterated an Overweight rating and $356.00 price target on Molina Healthcare (NYSE: MOH).

Joanna GajukBank of America Securities

Bank of America Securities

$309

Sell

6.46%

Upside

Reiterated

04/24/25

Cautious Outlook for Molina Healthcare Amid MLR Concerns and Medicaid Uncertainties

Ryan LangstonTD Cowen

TD Cowen

$342→$369

Buy

27.13%

Upside

Reiterated

04/24/25

Molina Healthcare (MOH) Gets a Buy from TD Cowen

Michael HaRobert W. Baird

Robert W. Baird

$331→$375

Hold

29.20%

Upside

Downgraded

04/14/25

Molina Healthcare downgraded to Neutral from Outperform at BairdMolina Healthcare downgraded to Neutral from Outperform at Baird

Ann HynesMizuho Securities

Mizuho Securities

$376→$400

Buy

37.81%

Upside

Reiterated

04/09/25

Molina Healthcare price target raised to $400 from $376 at MizuhoMolina Healthcare price target raised to $400 from $376 at Mizuho

Jason CassorlaGuggenheim

Guggenheim

―

Hold

―

Initiated

04/08/25

Guggenheim starts Molina Healthcare (MOH) at NeutralGuggenheim analyst Jason Cassorla initiates coverage on Molina Healthcare (NYSE: MOH) with a Neutral rating.

John StanselJ.P. Morgan

J.P. Morgan

$350→$333

Hold

14.73%

Upside

Reiterated

02/12/25

Molina Healthcare (MOH) PT Lowered to $333 at JPMorganJPMorgan analyst John Stansel lowered the price target on Molina Healthcare (NYSE: MOH) to $333.00 (from $350.00) while maintaining a Neutral rating.

George HillDeutsche Bank

Deutsche Bank

$391→$369

Hold

27.13%

Upside

Reiterated

02/07/25

Molina Healthcare price target lowered to $369 from $391 at Deutsche BankMolina Healthcare price target lowered to $369 from $391 at Deutsche Bank

Unknown AnalystUBS

Not Ranked

UBS

$325

Hold

11.97%

Upside

Reiterated

02/07/25

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$350

Buy

20.59%

Upside

Reiterated

05/23/25

Erin WrightMorgan Stanley

Morgan Stanley

$364

Buy

25.41%

Upside

Initiated

06/09/25

Molina Healthcare initiated with an Overweight at Morgan StanleyMolina Healthcare initiated with an Overweight at Morgan Stanley

Andrew Mok CFABarclays

Barclays

$351→$347

Hold

19.55%

Upside

Reiterated

06/09/25

Barclays Remains a Hold on Molina Healthcare (MOH)

Lance WilkesBernstein

Bernstein

$414

Buy

42.64%

Upside

Reiterated

06/06/25

Molina Healthcare (MOH) Receives a Buy from Bernstein

Stephen BaxterWells Fargo

Wells Fargo

$403→$372

Buy

28.17%

Upside

Reiterated

06/05/25

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (NYSE: MOH), Zai Lab (NASDAQ: ZLAB) and Guardant Health (NASDAQ: GH)

David S MacdonaldTruist Financial

Truist Financial

$400

Buy

37.81%

Upside

Reiterated

04/28/25

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (NYSE: MOH), Neurocrine (NASDAQ: NBIX) and Viking Therapeutics (NASDAQ: VKTX)

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$356

Buy

22.65%

Upside

Reiterated

04/24/25

Joanna GajukBank of America Securities

Bank of America Securities

$309

Sell

6.46%

Upside

Reiterated

04/24/25

Cautious Outlook for Molina Healthcare Amid MLR Concerns and Medicaid Uncertainties

Ryan LangstonTD Cowen

TD Cowen

$342→$369

Buy

27.13%

Upside

Reiterated

04/24/25

Molina Healthcare (MOH) Gets a Buy from TD Cowen

Michael HaRobert W. Baird

Robert W. Baird

$331→$375

Hold

29.20%

Upside

Downgraded

04/14/25

Molina Healthcare downgraded to Neutral from Outperform at BairdMolina Healthcare downgraded to Neutral from Outperform at Baird

Ann HynesMizuho Securities

Mizuho Securities

$376→$400

Buy

37.81%

Upside

Reiterated

04/09/25

Molina Healthcare price target raised to $400 from $376 at MizuhoMolina Healthcare price target raised to $400 from $376 at Mizuho

Jason CassorlaGuggenheim

Guggenheim

―

Hold

―

Initiated

04/08/25

Guggenheim starts Molina Healthcare (MOH) at NeutralGuggenheim analyst Jason Cassorla initiates coverage on Molina Healthcare (NYSE: MOH) with a Neutral rating.

John StanselJ.P. Morgan

J.P. Morgan

$350→$333

Hold

14.73%

Upside

Reiterated

02/12/25

George HillDeutsche Bank

Deutsche Bank

$391→$369

Hold

27.13%

Upside

Reiterated

02/07/25

Molina Healthcare price target lowered to $369 from $391 at Deutsche BankMolina Healthcare price target lowered to $369 from $391 at Deutsche Bank

Unknown AnalystUBS

Not Ranked

UBS

$325

Hold

11.97%

Upside

Reiterated

02/07/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Molina Healthcare

1 Month

xxx

Success Rate

11/18 ratings generated profit

Average Return

+2.14%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 61.11% of your transactions generating a profit, with an average return of +2.14% per trade.

3 Months

xxx

Success Rate

17/25 ratings generated profit

Average Return

+8.57%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 68.00% of your transactions generating a profit, with an average return of +8.57% per trade.

1 Year

Sarah JamesCantor Fitzgerald

Success Rate

18/25 ratings generated profit

Average Return

+31.00%

reiterated a buy rating 2 months ago

Copying Sarah James's trades and holding each position for 1 Year would result in 72.00% of your transactions generating a profit, with an average return of +31.00% per trade.

2 Years

xxx

Success Rate

19/25 ratings generated profit

Average Return

+47.57%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 76.00% of your transactions generating a profit, with an average return of +47.57% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MOH Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MOH has received 11 Buy Ratings, 6 Hold Ratings, and 1 Sell Ratings. MOH average Analyst price target in the past 3 months is 370.60.

Each month's total comprises the sum of three months' worth of ratings.

MOH Financial Forecast

MOH Earnings Forecast

Next quarter’s earnings estimate for MOH is $6.20 with a range of $5.75 to $6.87. The previous quarter’s EPS was $6.08. MOH beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.02% of the time in the same period. In the last calendar year MOH has Outperformed its overall industry.

MOH Sales Forecast

Next quarter’s sales forecast for MOH is $10.92B with a range of $10.48B to $11.23B. The previous quarter’s sales results were $11.15B. MOH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year MOH has Outperformed its overall industry.

MOH Stock Forecast FAQ

What is MOH’s average 12-month price target, according to analysts?

Based on analyst ratings, Molina Healthcare’s 12-month average price target is 370.60.

What is MOH’s upside potential, based on the analysts’ average price target?

Molina Healthcare has 27.68% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MOH a Buy, Sell or Hold?

Molina Healthcare has a consensus rating of Moderate Buy which is based on 7 buy ratings, 3 hold ratings and 1 sell ratings.

What is Molina Healthcare’s price target?

The average price target for Molina Healthcare is 370.60. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $414.00 ,the lowest forecast is $309.00. The average price target represents 27.68% Increase from the current price of $290.25.

What do analysts say about Molina Healthcare?

Molina Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of MOH?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Molina Healthcare (MOH) Stock Forecast & Price Target

MOH Analyst Ratings

MOH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Molina Healthcare

MOH Analyst Recommendation Trends

MOH Financial Forecast

MOH Earnings Forecast

MOH Sales Forecast

MOH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts